Zobrazeno 1 - 10
of 12
pro vyhledávání: '"da Silva HG"'
Autor:
Valente da Silva HG (AUTHOR), Santos SO (AUTHOR), Silva NO (AUTHOR), Ribeiro FD (AUTHOR), Josua LL (AUTHOR), Moreira AS (AUTHOR)
Publikováno v:
Nutrición Hospitalaria. mar/abr2012, Vol. 27 Issue 2, p542-547. 6p.
Autor:
Meeraus W; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK. Electronic address: wilhelmine.meeraus@astrazeneca.com., Stuurman AL; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Durukal I; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Conde-Sousa E; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK; P95 Epidemiology & Pharmacovigilance, Leuven, Belgium., Lee A; Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Cambridge, UK., Maria AS; Evidence Generation, AstraZeneca, São Paulo, Brazil., Furtado BE; Vaccines & Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, São Paulo, Brazil., Ouwens M; Medical and Payor Statistics, BioPharmaceuticals Business Unit, AstraZeneca, Mölndal, Sweden., Gray CM; Real World Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Valverde DA; Techtrials Healthcare Data Science, São Paulo, Brazil., da Silva HG; Formerly BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Taylor S; Medical Evidence, Vaccines & Immune Therapies, AstraZeneca, Cambridge, UK.
Publikováno v:
Vaccine [Vaccine] 2023 Oct 06; Vol. 41 (42), pp. 6366-6378. Date of Electronic Publication: 2023 Sep 12.
Autor:
Soboleva K; Clinical Development, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Durham, NC, USA., Shankar NK; Patient Safety, Chief Medical Office, R&D, AstraZeneca India, Bangalore, India., Yadavalli M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gaithersburg, MD, USA., Ferreira C; BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA., Foskett N; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Putsepp K; BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA., Ferstenberg LB; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gaithersburg, MD, USA., Nord M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden., da Silva HG; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Bhuyan P; Clinical Development, Late-stage Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. Electronic address: prakash.bhuyan@astrazeneca.com.
Publikováno v:
The Lancet. Global health [Lancet Glob Health] 2022 Jan; Vol. 10 (1), pp. e33-e34.
Autor:
Bhuyan P; Clinical Development, Late-stage Development, Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD, USA., Medin J; BioPharmaceuticals Medical, AstraZeneca, Gothenburg SE431 83, Sweden., da Silva HG; BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK., Yadavalli M; Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gaithersburg, MD, USA., Nord M; Patient Safety, Chief Medical Office, Research and Development, AstraZeneca, Gothenburg SE431 83, Sweden. Electronic address: magnus.nord@astrazeneca.com.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Nov 13; Vol. 398 (10313), pp. 1801-1802.
Autor:
da Silveira AA; Laboratório de Química de Polímeros (LQP) - ICB2, Universidade Federal de Goiás, Goiânia, Brazil.; Faculdade Estácio de Sá de Goiás - FESGO, Goiânia, Brazil., Andrade JSP; Laboratório de Química de Polímeros (LQP) - ICB2, Universidade Federal de Goiás, Goiânia, Brazil.; Faculdade Estácio de Sá de Goiás - FESGO, Goiânia, Brazil., Guissoni ACP; Faculdade Estácio de Sá de Goiás - FESGO, Goiânia, Brazil., da Costa AC; Faculdade Estácio de Sá de Goiás - FESGO, Goiânia, Brazil., de Carvalho E Silva A; Faculdade Estácio de Sá de Goiás - FESGO, Goiânia, Brazil., da Silva HG; DBBM- ICB2, Universidade Federal de Goiás, Goiânia, Brazil., Brito P; IPTSP - Universidade Federal de Goiás, Goiânia, Brazil., de Souza GRL; ICB4/Universidade Federal de Goiás, Goiânia, Brazil., Fernandes KF; Laboratório de Química de Polímeros (LQP) - ICB2, Universidade Federal de Goiás, Goiânia, Brazil.
Publikováno v:
Biotechnology progress [Biotechnol Prog] 2021 Sep; Vol. 37 (5), pp. e3182. Date of Electronic Publication: 2021 Jun 26.
Autor:
Bhuyan P; Global Clinical Development Late R&I, AstraZeneca, Gaithersburg, MD, USA., Medin J; Global Medical BioPharmaceuticals, AstraZeneca, Gothenberg SE431 83, Sweden., da Silva HG; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK., Yadavalli M; Global Patient Safety BioPharmaceuticals, AstraZeneca, Gaithersburg, MD, USA., Shankar NK; Global Patient Safety BioPharmaceuticals, AstraZeneca, Bangalore, India., Mullerova H; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK., Arnold M; Global Medical BioPharmaceuticals, AstraZeneca, Cambridge, UK., Nord M; Global Patient Safety BioPharmaceuticals, AstraZeneca, Gothenberg SE431 83, Sweden. Electronic address: magnus.nord@astrazeneca.com.
Publikováno v:
Lancet (London, England) [Lancet] 2021 Aug 14; Vol. 398 (10300), pp. 577-578. Date of Electronic Publication: 2021 Jul 27.
Autor:
Valente-Da-Silva HG; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brasil., Maya MCA; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brasil., Moreira AS; Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brasil.
Publikováno v:
Revista do Colegio Brasileiro de Cirurgioes [Rev Col Bras Cir] 2017 May-Jun; Vol. 44 (3), pp. 263-269.
Autor:
da Silva HG; Faculty of Medical Sciences of the Universidade Estadual de Campinas (FM UNICAMP) - Campinas, SP, Brazil., Cliquet Junior A; Faculty of Medical Sciences of the Universidade Estadual de Campinas (FM UNICAMP) - Campinas, SP, Brazil., Zorzi AR; Faculty of Medical Sciences of the Universidade Estadual de Campinas (FM UNICAMP) - Campinas, SP, Brazil., Batista de Miranda J; Faculty of Medical Sciences of the Universidade Estadual de Campinas (FM UNICAMP) - Campinas, SP, Brazil.
Publikováno v:
Acta ortopedica brasileira [Acta Ortop Bras] 2012; Vol. 20 (3), pp. 150-6.
Autor:
Zorzi AR; Department of Orthopaedic Surgery, Campinas' State University (UNICAMP), Campinas, São Paulo, Brazil. alessandrozorzi@uol.com.br, da Silva HG, Muszkat C, Marques LC, Cliquet A Jr, de Miranda JB
Publikováno v:
Artificial organs [Artif Organs] 2011 Mar; Vol. 35 (3), pp. 301-7. Date of Electronic Publication: 2010 Dec 06.
Autor:
van Luin M; Department of Clinical Pharmacy, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. m.vanluin@akf.umcn.nl, Colbers A, van Ewijk-Beneken Kolmer EW, Verweij-van Wissen CP, Schouwenberg B, Hoitsma A, da Silva HG, Burger DM
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2010 Sep; Vol. 55 (1), pp. 82-6.